Foundation for Angelman Syndrome Therapeutics

The Foundation for Angelman Syndrome Therapeutics (FAST) is committed to accelerating treatments and a cure for Angelman syndrome (AS). The symptoms of AS have been under-addressed in the research community for far too long. Research aimed at identifying treatments for the motor dysfunction, seizures and behavioral characteristics of Angelman syndrome is one of FAST's top priorities. Our goal is to bring practical treatment into current medical practice as quickly as possible. It is our hope that grants we fund will lead to additional research support from government agencies, other funding sources and organizations around the globe.

Headquarter Address

P.O. Box 608
Downers Grove, IL 60515